Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sarcoma lung surveillance study halted early: x-ray vs CT debate unresolved

NCT ID NCT01612481

Knowledge-focused Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aimed to compare chest X-ray and CT scans for detecting lung metastases in people who had surgery for high-grade soft tissue sarcoma. Only 11 patients were enrolled before the study was terminated early. The goal was to see which method better finds isolated, operable lung spread, but the small size limits what can be learned.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help determine the best way to monitor for lung cancer spread after sarcoma surgery, potentially reducing unnecessary scans and anxiety.
What could go wrong
The study was terminated early with only 11 participants, so results are very limited and may not provide clear answers. It is a small, early-phase trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

11 people

The number who actually took part.

Started

Apr 2012

Finished

May 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * soft tissue sarcoma, histologically proven * tumor size \> 5 cm (SBR grade 2) or whatever size (SBR grade 3) * complete excision (R0 or R1) * no metastasis (checked by spiral chest CT) * social security covered * informed signed consent Exclusion Criteria: * bone, visceral, uterine, retroperitoneal sarcoma * GIST * other malignant tumor * patients over 70, or for whom thoracic surgery is excluded * pneumoconiosis or known system disease * breast feeding or pregnant woman * patient unable to undergo trail medical follow up for geographic, social or psychological reasons

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung metastasis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung metastasis Soft tissue sarcoma

Contacts and locations

Locations

  • Centre Georges François Leclerc

    Dijon, 21079, France

  • Léon BERARD Center

    Lyon, 69008, France

  • Oscar Lambret Center

    Lille, 59020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.